Genetic risk scores may improve clinical identification of patients with heart attack risk

June 02, 2020

Genetic variants have been linked with a higher risk of having a heart attack, permitting the calculation of "polygenic risk scores" (PRS) that quantify patients' inherited susceptibility based on the number of variants they have.

A team led by investigators at Massachusetts General Hospital and the Broad Institute of Massachusetts Institute of Technology and Harvard recently found that applying PRS can identify at-risk patients who are not presently identified through standard clinical evaluations.

In a study reported in the Journal of the American College of Cardiology, the team applied PRS to 47,108 individuals who were an average of 60 years old and were receiving care across three U.S. health care systems (in Massachusetts, Pennsylvania and New York). The PRS strongly associated with the presence of coronary artery disease, which is the cause of heart attacks. Specifically, those with scores in the top 20% were 1.9-times more likely to have developed disease compared with the remaining 80% of the population. Importantly, those with high PRS were not more likely than others to have been previously recognized as high risk by their physicians.

"We identified a subset of individuals at double the risk of heart attack on the basis of their genes. Despite this elevated risk, these individuals were neither more likely to be flagged as high risk, nor more likely to receive preventive statin therapy per our conventional clinical practices--a consistent finding across all three health systems studied," said lead author Krishna Aragam, MD, a cardiologist at Mass General and an instructor in Medicine at Harvard Medical School.

The researchers determined that if coronary artery disease PRS were considered alongside current national guidelines, an additional 4.1% of patients who have not yet experienced a heart attack may be recommended to receive cholesterol-lowering statins. "When coupled with clinical assessments, we estimate that genetic testing may uniquely identify a need for preventive statin therapy in approximately 1 in every 25 of such patients," said Dr. Aragam.

The authors note that assessments of polygenic risk are becoming more pervasive through research-based and direct-to-consumer services. They suggest that calculating patients' genetic risk for heart attacks may help to improve upon current clinical assessments of risk, particularly in situations of clinical uncertainty. "Within our present frameworks for heart attack prevention, we speculate that genetic testing may be most immediately useful to guide clinical management for patients otherwise falling in a 'gray area' of intermediate risk based on standard clinical factors," Dr. Aragam said.
-end-
Paper cited: Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease Aragam KG, Dobbyn A, Judy R, Chaffin M, Chaudhary K, Hindy G, Cagan A, Finneran P, Weng L, Loos RJF, Nadkarni G, Cho JH, Kember RL, Baras A, Reid J, Overton J, Philippakis A, Ellinor PT, Weiss ST, Rader DJ, Lubitz SA, Smoller JW, Karlson EW, Khera AV, Kathiresan S, Do R, Damrauer SM, Natarajan P J Am Coll Cardiol. 2020 Jun, 75 (22) 2769-2780.

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2019, Mass General was named #2 in the U.S. News & World Report list of "America's Best Hospitals."

Massachusetts General Hospital

Related Heart Attack Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

Muscle protein abundant in the heart plays key role in blood clotting during heart attack
A prevalent heart protein known as cardiac myosin, which is released into the body when a person suffers a heart attack, can cause blood to thicken or clot--worsening damage to heart tissue, a new study shows.

New target identified for repairing the heart after heart attack
An immune cell is shown for the first time to be involved in creating the scar that repairs the heart after damage.

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.

A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.

Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.

Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.

Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.

How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.

Read More: Heart Attack News and Heart Attack Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.